Literature DB >> 26085859

Correlation of Primary Tumor FDG Uptake with Histopathologic Features of Advanced Gastric Cancer.

Hae Won Kim1, Kyoung Sook Won1, Bong-Il Song1, Yu Na Kang2.   

Abstract

PURPOSE: Histopathologic features could affect the FDG uptake of primary gastric cancer and detection rate on FDG PET/CT. The aim of this study was to evaluate the FDG uptake of primary gastric cancer by correlating it with the histopathologic features of the tumors.
METHODS: Fifty patients with locally advanced gastric adenocarcinoma who were referred for preoperative FDG-PET/CT scans were enrolled in this study. The detection rate of PET/CT and maximum standardized uptake values (SUVmax) of the primary tumor were compared using the WHO, Lauren, Ming and Borrmann classifications and tumor size and location.
RESULTS: In 45 of the 50 patients (90 %), the primary gastric tumors were detected by FDG PET/CT. On comparison using the WHO classification, the detection rate and SUVmax of the tubular type were significantly higher than those of the poorly cohesive type. On comparison using the Lauren and Ming classifications, the SUVmaxs of the intestinal type and expanding type were significantly higher than those of the diffuse and infiltrative type, respectively. On comparison using the Borrmann classification and tumor size and location, there was no significant difference in the detection rate and SUVmax of primary gastric tumors.
CONCLUSION: This study demonstrates that the poorly cohesive type according to the WHO classification, diffuse type according to the Lauren classification and infiltrative type according to the Ming classification have low FDG uptake in patients with locally advanced gastric carcinoma. Understanding the relationship between primary tumor FDG uptake and histopathologic features would be helpful in detecting the primary tumor by FDG PET/CT in patients with gastric cancer.

Entities:  

Keywords:  FDG; Gastric carcinoma; Lauren classification; Ming classification; PET/CT; WHO classification

Year:  2015        PMID: 26085859      PMCID: PMC4463880          DOI: 10.1007/s13139-015-0327-3

Source DB:  PubMed          Journal:  Nucl Med Mol Imaging        ISSN: 1869-3474


  43 in total

Review 1.  Modern staging in gastric cancer.

Authors:  J Tschmelitsch; M R Weiser; M S Karpeh
Journal:  Surg Oncol       Date:  2000-07       Impact factor: 3.279

2.  [18F]-fluorodeoxyglucose-positron emission tomography for the assessment of histopathologic response and prognosis after completion of neoadjuvant chemotherapy in gastric cancer.

Authors:  D Vallböhmer; A H Hölscher; P M Schneider; M Schmidt; M Dietlein; E Bollschweiler; S Baldus; H Alakus; J Brabender; R Metzger; S P Mönig
Journal:  J Surg Oncol       Date:  2010-08-01       Impact factor: 3.454

3.  Pathologic and phenotypic features of gastric cancer.

Authors:  C M Fenoglio-Preiser; A E Noffsinger; J Belli; G N Stemmermann
Journal:  Semin Oncol       Date:  1996-06       Impact factor: 4.929

4.  FDG PET evaluation of mucinous neoplasms: correlation of FDG uptake with histopathologic features.

Authors:  K L Berger; S A Nicholson; F Dehdashti; B A Siegel
Journal:  AJR Am J Roentgenol       Date:  2000-04       Impact factor: 3.959

5.  Prediction of response and prognosis by a score including only pretherapeutic parameters in 410 neoadjuvant treated gastric cancer patients.

Authors:  Sylvie Lorenzen; Susanne Blank; Florian Lordick; Jörg-Rüdiger Siewert; Katja Ott
Journal:  Ann Surg Oncol       Date:  2012-03-07       Impact factor: 5.344

6.  Signet ring cell type and other histologic types: differing clinical course and prognosis in T1 gastric cancer.

Authors:  Beom Su Kim; Seong Tae Oh; Jeong Hwan Yook; Byung Sik Kim
Journal:  Surgery       Date:  2014-04-29       Impact factor: 3.982

7.  Role of ¹⁸F-FDG PET/CT in the prediction of gastric cancer recurrence after curative surgical resection.

Authors:  Jeong Won Lee; Sang Mi Lee; Moon-Soo Lee; Hyeong Cheol Shin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-06-07       Impact factor: 9.236

8.  Discussion of modifying stage IV gastric cancer based on Borrmann classification.

Authors:  Bin Yang; Guoqiang Wu; Xiaochen Wang; Xuefeng Zhang
Journal:  Tumour Biol       Date:  2013-02-13

9.  Detection of recurrent oral squamous cell carcinoma by [18F]-2-fluorodeoxyglucose-positron emission tomography: implications for prognosis and patient management.

Authors:  Martin Kunkel; Gregor J Förster; Torsten E Reichert; Jong-Hyeon Jeong; Peter Benz; Peter Bartenstein; Wilfried Wagner; Theresa L Whiteside
Journal:  Cancer       Date:  2003-11-15       Impact factor: 6.860

10.  Histological grading in gastric cancer by Ming classification: correlation with histopathological subtypes, metastasis, and prognosis.

Authors:  Thomas Luebke; Stephan E Baldus; Guido Grass; Elfriede Bollschweiler; Jürgen Thiele; Hans-Peter Dienes; Arnulf H Hoelscher; Stefan P Moenig
Journal:  World J Surg       Date:  2005-11       Impact factor: 3.282

View more
  5 in total

1.  Clinical implication of FDG uptake of bone marrow on PET/CT in gastric cancer patients with surgical resection.

Authors:  Jeong Won Lee; Moon-Soo Lee; Il Kwon Chung; Myoung Won Son; Young Sin Cho; Sang Mi Lee
Journal:  World J Gastroenterol       Date:  2017-04-07       Impact factor: 5.742

2.  Relationship of FDG PET/CT Textural Features with the Tumor Microenvironment and Recurrence Risks in Patients with Advanced Gastric Cancers.

Authors:  Hyein Ahn; Geum Jong Song; Si-Hyong Jang; Hyun Ju Lee; Moon-Soo Lee; Ji-Hye Lee; Mee-Hye Oh; Geum Cheol Jeong; Sang Mi Lee; Jeong Won Lee
Journal:  Cancers (Basel)       Date:  2022-08-15       Impact factor: 6.575

3.  18F-FDG uptake in the stomach on screening PET/CT: value for predicting Helicobacter pylori infection and chronic atrophic gastritis.

Authors:  Shigeki Kobayashi; Mayumi Ogura; Naohisa Suzawa; Noriyuki Horiki; Masaki Katsurahara; Toru Ogura; Hajime Sakuma
Journal:  BMC Med Imaging       Date:  2016-10-18       Impact factor: 1.930

4.  Clinicopathologic parameters associated with the FDG-avidity in staging of early gastric cancer using 18F-FDG PET.

Authors:  Joon-Kee Yoon; Cheulsu Byun; Kyung Sook Jo; Hun Hur; Kee Myung Lee; Seon Kyo Lim; Dakeun Lee; Su Jin Lee; Young-Sil An; Sang-Uk Han
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

5.  Establishment of a [18F]-FDG-PET/MRI Imaging Protocol for Gastric Cancer PDX as a Preclinical Research Tool.

Authors:  Seong-Woo Bae; Felix Berlth; Kyoung-Yun Jeong; Yun-Suhk Suh; Seong-Ho Kong; Hyuk-Joon Lee; Woo Ho Kim; June-Key Chung; Han-Kwang Yang
Journal:  J Gastric Cancer       Date:  2020-02-21       Impact factor: 3.720

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.